These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 9177391)

  • 1. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
    Wise S; Nielsen M; Rizza R
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-dependent control of hepatic glycogen stores in healthy humans.
    Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
    Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
    Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
    Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
    Roden M; Stingl H; Chandramouli V; Schumann WC; Hofer A; Landau BR; Nowotny P; Waldhäusl W; Shulman GI
    Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.
    Adkins A; Basu R; Persson M; Dicke B; Shah P; Vella A; Schwenk WF; Rizza R
    Diabetes; 2003 Sep; 52(9):2213-20. PubMed ID: 12941759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes.
    Kishore P; Gabriely I; Cui MH; Di Vito J; Gajavelli S; Hwang JH; Shamoon H
    Diabetes; 2006 Mar; 55(3):659-66. PubMed ID: 16505228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans.
    Clore JN; Stillman JS; Li J; O'Keefe SJ; Levy JR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E358-65. PubMed ID: 15082421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus.
    Wise SD; Nielsen MF; Cryer PE; Rizza RA
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2461-9. PubMed ID: 9661629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans.
    Dufour S; Lebon V; Shulman GI; Petersen KF
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E231-5. PubMed ID: 19458062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
    Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA
    Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.
    Nielsen MF; Basu R; Wise S; Caumo A; Cobelli C; Rizza RA
    Diabetes; 1998 Nov; 47(11):1735-47. PubMed ID: 9792543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
    Carey PE; Gerrard J; Cline GW; Dalla Man C; English PT; Firbank MJ; Cobelli C; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.